Bionano Genomics, Inc. BNGO
Bionano Genomics, Inc. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Operating margin | -116.9% | -337.9% | -596.0% | -473.7% | -428.8% | -453.4% | -255.4% | -170.1% | -244.3% |
| Net margin | -92.6% | -364.0% | -643.7% | -476.9% | -402.8% | -483.4% | -294.3% | -154.1% | -245.8% |
| FCF margin | — | — | — | — | — | -450.6% | -292.1% | -169.0% | -229.7% |
| Return on assets | -35.9% | -146.1% | -108.4% | -43.1% | -19.2% | -68.0% | -98.7% | -74.6% | -230.3% |
| Return on equity | -59.4% | -316.7% | -241.8% | -53.2% | -21.5% | -117.2% | -825.2% | -182.5% | 46.5% |
| Debt / equity | — | — | — | — | 0.00× | 0.47× | 5.56× | 0.89× | -0.00× |
| Current ratio | 1.98 | 1.06 | 1.40 | 4.38 | 12.47 | 5.23 | 1.07 | 5.09 | 0.43 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.